An updated review of antidepressants with marked serotonergic effects in obsessive–compulsive disorder

Serotonergic Drugs for Depression and Beyond

(2013) Stephen M. Stahl et al.   CURRENT DRUG TARGETS

5-HT3 receptor influences the washing phenotype and visual organization in obsessive-compulsive disorder supporting 5-HT3 receptor antagonists as novel treatment option

(2013) Leonhard Lennertz et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Ondansetron augmentation in patients with obsessive-compulsive disorder who are inadequate responders to serotonin reuptake inhibitors: Improvement with treatment and worsening following discontinuation

(2013) Stefano Pallanti et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Augmentation strategies in obsessive–compulsive disorder

(2013) Shyam Sundar Arumugham et al.   Expert Review of Neurotherapeutics

Sleep and obsessive-compulsive disorder (OCD)

(2013) Jessica L. Paterson et al.   SLEEP MEDICINE REVIEWS

Pharmacotherapy of obsessive-compulsive disorder: Evidence-based treatment and beyond

(2012) Naomi A Fineberg et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

A Case of Obsessive-Compulsive Disorder Successfully Treated With Agomelatine Monotherapy

(2012) Domenico De Berardis et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Neurotrophic factors in obsessive-compulsive disorder

(2012) Leonardo F. Fontenelle et al.   PSYCHIATRY RESEARCH

Sensory phenomena associated with repetitive behaviors in obsessive-compulsive disorder: An exploratory study of 1001 patients

(2012) Ygor Arzeno Ferrão et al.   PSYCHIATRY RESEARCH

Brain Regionalα-[11C]Methyl-L-Tryptophan Trapping in Medication-Free Patients With Obsessive-Compulsive Disorder

(2011) Alexandre Berney   ARCHIVES OF GENERAL PSYCHIATRY

Is Circadian Rhythm Disruption Important in Obsessive-Compulsive Disorder (OCD)? A Case of Successful Augmentation With Agomelatine for the Treatment of OCD

(2011) Felipe Filardi da Rocha et al.   CLINICAL NEUROPHARMACOLOGY

Pharmacological Management of Treatment-Resistant Obsessive-Compulsive Disorder

(2011) Anat Abudy et al.   CNS DRUGS

The role of glutamate signaling in the pathogenesis and treatment of obsessive–compulsive disorder

(2011) Ke Wu et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Switching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: a 3 month follow-up case series

(2011) Michele Fornaro   Annals of General Psychiatry

A double-blind, placebo-controlled pilot study of ondansetron for patients with obsessive-compulsive disorder

(2010) Farhad Soltani et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Quality of life and symptom dimensions of patients with obsessive–compulsive disorder

(2010) Isabela S. Fontenelle et al.   PSYCHIATRY RESEARCH

High-Dose Duloxetine for Treatment-Resistant Obsessive-Compulsive Disorder

(2009) Yi-Wei Yeh et al.   CLINICAL NEUROPHARMACOLOGY

Obsessive-compulsive disorder

(2009) Jonathan S Abramowitz et al.   LANCET

Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: Systematic review

(2008) Michael H. Bloch et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Review: Intravenous anti-obsessive agents: a review

(2008) LN Ravindran et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Switching from serotonin reuptake inhibitors to duloxetine in patients with resistant obsessive compulsive disorder: a case series

(2008) Bernardo Dell'Osso et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication

(2008) A M Ruscio et al.   MOLECULAR PSYCHIATRY